Epidemiology of diabetic nephropathy

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 1-7

  Reutens, Anne T ^a   Atkins, Robert C ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; HUMAN; MORTALITY; PREVALENCE;

ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; PREVALENCE;

EID: 79959282613     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324934     Document Type: Article

References (35)

1. Mogensen C, Christensen C: Predicting diabetic nephropathy in insulin-dependent patients. N Eng J Med 1984;311:89-93. (Pubitemid 14084080)
2. Mogensen C: Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Eng J Med 1986; 310:356-360. (Pubitemid 14179541)
3. Shaw J, Sicree R, Zimmet P: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
4. Zimmet P, Alberti K, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787. (Pubitemid 34000780)
5. Rossing P: Diabetic nephropathy: Worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 2006;6: 479-483. (Pubitemid 44896409)
6. Barr E, Magliano D, Zimmet P, et al: AusDiab 2005. The Australian Diabetes, Obesity and Lifestyle Study. Tracking the accelerating epidemic: Its causes and outcomes. Melbourne, International Diabetes Institute, 2006.
7. McDonald S, Excell L, Livingston B: Appendix II, in ANZDATA Registry Report 2008. Adelaide, 2008.
8. Postma M, de Zeeuw D: The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2009;24:2975-2983.
9. Trivedi H, Pang M, Campbell A, Saab P: Slowing the progression of chronic renal failure: Economic benefits and patients' perspectives. Am J Kidney Dis 2002;39: 721-729. (Pubitemid 34263345)
10. Lopes A: End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethn Dis 2009; 19(suppl 1):S1-47-51.
11. Andersen A, Christiansen J, Andersen J, Kreiner S, Deckert T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 1983;25: 496-501. (Pubitemid 14200886)
12. Krolewski A, Warram J, Christlieb A, Busick E, Kahn C: The changing natural history of nephropathy in type 1 diabetes. Am J Med 1985;78:785-794. (Pubitemid 15008233)
13. Molitch M, Steffes M, Sun W, et al: Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 2010; 33:1536-1543.
14. Pambianco G, Costacou T, Ellis D, Becker D, Klein R, Orchard T: The 30-year natural history of type 1 diabetes complications. The Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006;55:1463-1469. (Pubitemid 44195388)
15. Stadler M, Auinger M, Anderwald C, et al: Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus. J Clin Endocrinol Metab 2006;91:3814-3820. (Pubitemid 44536848)
16. Nishimura R, Dorman J, Bosnyak Z, Tajima N, Becker D, Orchard T: Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: A report from the Allegheny County Registry. Am J Kidney Dis 2003;42:117-124. (Pubitemid 36807660)
17. Finne P, Reunanen A, Stenman S, Groop P, Gronhagen-Riska C: Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005 294:1782-1787. (Pubitemid 41434624)
18. Burrows N, Li Y, Geiss L: Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010;33:73-77.
19. Adler A, Stevens R, Manley S, Bilous R, Cull C, Holman R, UKPDS group: Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-232. (Pubitemid 35463925)
20. Bruno G, Merletti F, Biggeri A, et al: Progression to overt nephropathy in type 2 diabetes: The Casale Monferrato Study. Diabetes Care 2003;26:2150-2155. (Pubitemid 41184267)
21. Gall M, Hougaard P, Borch-Johnsen K, Parving H: Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study. BMJ 1997;314:783-788. (Pubitemid 27117048)
22. Nelson R, Knowler W, McCance D, et al: Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulindependent) diabetes mellitus and proteinuria. Diabetologia 1993;36:1087-1093. (Pubitemid 23288780)
23. US Renal Data System: USRDS 2010 Annual Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases, 2010.
24. Perkins B, Ficociello L, Silva K, Finkelstein D, Warram J, Krolewski A: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003;348:2285-2293. (Pubitemid 36638102)
25. Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D: Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 2005;54:2983-2987. (Pubitemid 41401096)
26. Rossing P, Hougaard P, Parving H: Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: A 10-year prospective observational study. Diabetes Care 2002;25:859-864. (Pubitemid 41094283)
27. Vergouwe Y, Soedamah-Muthu S, Zgibor J, et al: Progression to microalbuminuria in type 1 diabetes: Development and validation of a prediction rule. Diabetologia 2010;53: 254-262.
28. Perkins B, Ficociello L, Roshan B, Warram J, Krolewski A: In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 2010;77:57-64.
29. Lane P, Steffes M, Mauer S: Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 1992;41:581-586.
30. Tsalamandris C, Allen T, Gilbert R, Sinha A, Panagiotopoulos S, Cooper M, Jerums G: Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 1994;43:649-655. (Pubitemid 24138777)
31. MacIsaac R, Tsalamandris C, Panagiotopoulos S, Smith T, McNeil K, Jerums G: Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004;27:195-200. (Pubitemid 38196732)
32. Kramer H, Nguyen Q, Curhan G, Hsu C: Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289:3273-3277. (Pubitemid 37430080)
33. Thomas M, Macisaac R, Jerums G, Weekes A, Moran J, Shaw J, Atkins R: Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 2009;32:1497-1502.
34. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010;375:2073-2081.
35. Gerstein H, Mann J, Yi Q, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426. (Pubitemid 32681484)